Inc., a company specializing in electromedical and electrotherapeutic apparatus with a market capitalization of $44 million, ...

BTIG lowered the firm’s price target on Outset Medical (OM) to $3 from $4 and keeps a Buy rating on the shares. The firm is updating its model ...

Inc. (NASDAQ:OM), reported several stock transactions, according to a recent SEC filing. The company's stock, currently trading at $0.78, has experienced significant volatility, falling nearly 80% ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Gilead Sciences (GILD – Research Report) and ...

Les Masterson is a deputy editor and insurance analyst at Forbes Advisor. He has been a journalist, reporter, editor and content creator for more than 25 years. He has covered insurance for a ...

SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), a medical technology company with a market capitalization of $52 million, announced the closure of a private placement offering and the ...

RBC Capital Mkts has recently reduced Outset Medical Inc (OM) stock to Sector Perform rating, as announced on August 8, 2024, according to Finviz. Earlier, on June 21, 2024, RBC Capital Mkts had ...

SAN JOSE, CA – Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), a medical technology company with a market capitalization of $52 million, announced the closure of a private placement offering and ...

Outset Medical's CEO will present at the J.P. Morgan Healthcare conference showcasing their innovative dialysis technology on January 15, 2025. Outset Medical, Inc., a medical technology company ...

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo®Hemodialysis System, FDA cleared for use from the ...